ARL6IP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.66733293838206E-12 |
Normal-vs-Stage2 |
4.11959999999656E-05 |
Normal-vs-Stage3 |
1.68769997976881E-10 |
Normal-vs-Stage4 |
6.61220000974794E-09 |
Stage1-vs-Stage2 |
8.260200E-01 |
Stage1-vs-Stage3 |
9.454800E-01 |
Stage1-vs-Stage4 |
2.390600E-01 |
Stage2-vs-Stage3 |
8.690800E-01 |
Stage2-vs-Stage4 |
3.227000E-01 |
Stage3-vs-Stage4 |
2.799800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62481139653892E-12 |
Normal-vs-AfricanAmerican |
2.08560000047875E-07 |
Normal-vs-Asian |
9.566100E-02 |
Caucasian-vs-AfricanAmerican |
9.426000E-02 |
Caucasian-vs-Asian |
7.538800E-01 |
AfricanAmerican-vs-Asian |
3.739000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.43689570931383E-15 |
Normal-vs-Female |
1.33226762955019E-15 |
Male-vs-Female |
6.640600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.80140000086249E-08 |
Normal-vs-Age(41-60Yrs) |
6.09512440519211E-14 |
Normal-vs-Age(61-80Yrs) |
2.24531504500192E-12 |
Normal-vs-Age(81-100Yrs) |
4.03300000000328E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.953200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.781600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.597600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.417200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.807040E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.204560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.60482999999045E-05 |
Normal-vs-Grade 2 |
1.8810508706224E-12 |
Normal-vs-Grade 3 |
1.86162196769146E-12 |
Normal-vs-Grade 4 |
1.20159999950076E-07 |
Grade 1-vs-Grade 2 |
9.285200E-01 |
Grade 1-vs-Grade 3 |
9.613200E-01 |
Grade 1-vs-Grade 4 |
5.237200E-01 |
Grade 2-vs-Grade 3 |
9.421400E-01 |
Grade 2-vs-Grade 4 |
2.958600E-01 |
Grade 3-vs-Grade 4 |
3.629800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.54090107129923E-12 |
Normal-vs-ccB subtype |
6.67050004121705E-09 |
ccA subtype-vs-ccB subtype |
8.078200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.04059982852789E-10 |
Normal-vs-N1 |
2.858500E-02 |
N0-vs-N1 |
4.360200E-01 |
|
|